登录

首页 > 资讯动态

FDA批准治疗慢性淋巴细胞白血病的新疗法 2019.11.21
CLL Calquence Project Orbis 研发注册

【FDA在国际合作下采取第二项行动，批准治疗慢性淋巴细胞白血病的新疗法】 For Immediate Release November 21, 2019 Today, as part of Project Orbis, a collaboration with the Australian Therapeutic Goods Administration (TGA) and Health Canada, the U.S. Foo...